|
|
|
| Plasma Level of Adrenocorticotropic Hormone and Clinical Significance in Type 2 Diabetes Mellitus Patients with Obesity |
| KANG Juge, DANG Qian |
| Chang'an Hospital, Shaanxi Xi'an 710016, China |
|
|
|
|
Abstract Objective: To investigate the Plasma adrenocorticotropic hormone (ACTH) level and clinical significance of type 2 diabetes mellitus (T2DM) patients with obesity. Methods: 102 T2DM patients with obesity treated in our hospital from January 2019 to June 2021 were selected as the research object and classified as the obesity group. At the same time, 100 T2DM patients without obesity treated in our hospital in the same period were selected as the non-obesity group, and 95 healthy adults who underwent physical examination in our hospital in the same period were selected as the control group. Fasting blood glucose (FPG), fasting insulin (fins), triglycerides (TG), total cholesterol (TC), homeostasis model insulin resistance index (HOMA-IR), plasma ACTH level and bone mineral density (BMD) were compared among the three groups. Pearson correlation analysis and multiple linear regression were used to explore the correlation between plasma ACTH level and various indexes in T2DM patients with obesity. Results: BMI, FPG, FINS, HOMA-IR, TG, TC and ACTH in obese group were significantly higher than those in the other two groups, and BMD was significantly lower than those in the other two groups. BMI, FPG, FINS, HOMA-IR, TG, TC and ACTH in non-obese group were significantly higher than those in the control group, and BMD was significantly lower than that in the control group (P<0.05). Pearson correlation analysis showed that the plasma ACTH level in obese patients was significantly positively correlated with BMI, FPG, FINS, HOMA-IR, TG and TC, and negatively correlated with BMD (P<0.05). Multiple linear regressions showed that BMI, FPG, HOMA-IR and BMD were the independent influencing factors of plasma ACTH level in obese patients (P<0.05). Conclusion: The plasma ACTH level of T2DM patients with obesity significantly increased, which was related to the disorder of glucose and lipid metabolism and the decrease of bone mineral density.
|
|
|
|
|
|
[1] 陈娇月,山秀杰,刘敏,等.骨化三醇联合二甲双胍对腹型肥胖2型糖尿病早期肾病的影响[J].河北医学,2020,26(4):602~605.
[2] 倪昶,郭颖,梁伟,等.2型糖尿病患者血清皮质醇与慢性并发症的关系[J].新医学,2021,52(4):260~264.
[3] 陈璟,李文亚,邵翔,等.血清皮质醇、促肾上腺皮质激素水平预测糖尿病肾病患者钙磷代谢紊乱价值分析[J].疑难病杂志,2021,20(8):770~774.
[4] 索艳,刘冬梅,王肃.西格列汀二甲双胍联合甘精胰岛素治疗初发肥胖2型糖尿病的疗效与安全性[J].中国慢性病预防与控制,2019,27(11):852~855.
[5] 傅奥博,谢雨婷,何斌斌,等.超重/肥胖2型糖尿病患者夜间皮质醇水平和微血管并发症的相关性分析[J].中华内分泌代谢杂志,2018,34(10):834~838.
[6] 周文军,何凤萍,杨祥康.分析15508例患者的促肾上腺皮质激素在高血压、糖尿病和矮小症中的诊断意义[J].中国卫生检验杂志,2021,31(6):756~757,760.
[7] 朱烨,张芃子,毕艳.血促肾上腺皮质激素、皮质醇水平及其节律与糖尿病肾病关系的研究[J].中华糖尿病杂志,2021,13(6):597~602.
[8] 张路遥,张会娟.2型糖尿病患者皮质醇与骨密度的相关性研究[J].河南医学研究,2018,27(17):3083~3087.
[9] 周高晋,邓力军,王莲朋,等.绝经后2型糖尿病女性骨代谢与脂代谢间的差异性[J].中国临床研究,2020,33(11):1463~1467.
[10] 吴黔鸣,王大寿,廖静,等.老年骨质疏松椎体压缩性骨折女性清晨糖皮质激素水平与骨密度的关系[J].贵州医药,2019,43(9):1388~1389. |
|
|
|
2022, Vol. 28 
